Pharmacology & Toxicology
Division Head
Richburg's research focuses on characterizing the molecular and cellular mechanisms that initiate testicular germ cells to undergo apoptosis after injury by environmental or chemotherapeutic agents.
Research & Graduate Training Faculty
Angel studies the genetics of susceptibility to carcinogen exposure using mouse models.
DiGiovanni's research focuses on understanding how cancer develops and on the identification of novel targets, mechanisms and strategies for cancer prevention.
Duvauchelle is exploring neural mechanisms of reward using behavioral, pharmacological, neurochemical & immunological methodologies.
The goal of Gonzales' lab is to understand the neurochemical basis for ethanol drinking behavior.
Gore's laboratory is interested in the mechanisms by which the brain controls reproductive development and aging.
Harris' laboratory is investigating structure and function of ion channels with emphasis on molecular mechanisms responsible for alcohol and drug actions.
Kiguchi's research is focusing on the role of erbB2 during biliary tract and esophageal carcinogenesis. In addition, under the long-term collaboration with Dr. John DiGiovanni (DPRI), his research explores the role of Stat3 and Akt signalings in epithelial carcinogenesis and cell proliferation.
Mihics' laboratory is focused on characterizing the molecular mechanisms through which alcohol, inhaled solvents, sedatives and anaesthetics act on ligand-activated ion channels.
Understanding mitochondrial and bioenergetic signaling mechanisms that contribute to age-related metabolic diseases such as obesity, diabetes, and cancer.
Morrisett's primary research interests center upon the role of amino-acid derived neurotransmitter systems and synaptic transmission in alterations that in underlie a variety of forms of neural functioning and pathologies.
Ponomarev's research focuses on two related questions: a) molecular mechanisms of alcohol addiction and b) molecular mechanisms of brain plasticity in response to genetic and pharmacological perturbations.
Van Den Berg's research focuses on the role of growth factor-mediated treatment resistance in breast cancer.
Vasquez' research efforts are focused in the areas of genome instability, DNA damage and mechanisms of repair. A unique feature of this lab's approach is an emphasis on the role of DNA structure in human disease, particularly on cancer-relevant chromosomal translocations, and the development of novel therapeutic strategies for treating cancer.
Wang's research activity is focused on understanding the effects of DNA modification and secondary structure on DNA damage/repair and genomic instability, and the cellular response to DNA damaging agents.
Wright's laboratory is focused on unraveling the complex regulatory mechanisms that govern the activity of the pluripotent transcription factor nuclear factor-kB (NF-kB).
Teaching and Administrative Faculty
Combs is interested in cardiovascular pharmacology and toxicology and in pharmacogenetics/genomics as well as distance education and the instructional uses of technology.
Erickson is interested in behavioral change methods and theory, attitudinal theory, and how to influence public opinion regarding drug use, abuse and dependence in our society.
Fineg is interested in computer-based animal care management.
|
|
Patterson,Wayne R. PHD
Associate Vice President for Research and
Director of the ORS
Adjunct Associate Professor
FAC 426
512-471-8873
wpatters@austin.utexas.edu |
Wilcox is interested in both agonist affinity at closely related receptors and science education in dual diagnosis patients.
Affiliate & Adjunct Faculty
Shawn B. Bratton, Ph.D.
David Crews, Ph.D.
Susan M. Fischer, Ph.D.
Francisco Gonzalez-Lima,
Ph.D.
Stephen D. Hursting,
Ph.D.
David Johnson,
Ph.D.
Kimberly Kline,
Ph.D.
Michael MacLeod,
Ph.D.
Dean Tang,
Ph.D.
Cheryl L. Walker,
Ph.D.
Teaching & Administrative Affiliate & Adjunct Faculty
Claudio J. Conti, DVM PhD.
Alan Frazer, Ph.D.
Roberta L. Grant, Ph.D.
John Ivy, Ph.D.
John O'Neill, H.S.D.
John F. Villanacci, Ph.D.
Program Coordinator
BME 3.510
Phone: 512-471-5096
Link to our
directories page for additional directory information.
(
Download PDF Reader.)
Last Reviewed: April 3, 2012
Dr. John DiGiovanni is part of a research team that has identified a gene that plays a role in susceptibility to nonmelanoma skin cancer.
